0001209191-14-076990.txt : 20141219
0001209191-14-076990.hdr.sgml : 20141219
20141219161504
ACCESSION NUMBER: 0001209191-14-076990
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141217
FILED AS OF DATE: 20141219
DATE AS OF CHANGE: 20141219
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 141299799
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-12-17
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2014-12-17
4
M
0
4800
10.41
A
343695
D
Common Stock
2014-12-17
4
M
0
1300
17.16
A
344995
D
Common Stock
2014-12-17
4
M
0
4400
35.64
A
349395
D
Common Stock
2014-12-17
4
S
0
6000
110.04
D
343395
D
Common Stock
2014-12-17
4
S
0
2800
111.13
D
340595
D
Common Stock
2014-12-17
4
S
0
1700
112.05
D
338895
D
Common Stock
13286
I
401(k)
Common Stock
172589
I
Common Stock held in trust
Stock Option (right to buy)
10.41
2014-12-17
4
M
0
4800
0.00
D
2015-02-02
Common Stock
4800
28988
D
Stock Option (right to buy)
17.16
2014-12-17
4
M
0
1300
0.00
D
2015-07-19
Common Stock
1300
39500
D
Stock Option (right to buy)
35.64
2014-12-17
4
M
0
4400
0.00
D
2016-02-01
Common Stock
4400
556000
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $110.04 (range $109.64 to $110.51).
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $111.13 (range $110.66 to $111.58).
Open market sales reported on this line occurred at a weighted average price of $112.05 (range $111.69 to $112.35).
Common stock held in grantor retained annuity trusts.
Fully vested.
Kenneth L. Horton, Attorney-In-Fact
2014-12-19